Astera Labs, Inc. (NASDAQ:ALAB) Receives $84.70 Average Target Price from Brokerages

Shares of Astera Labs, Inc. (NASDAQ:ALABGet Free Report) have been assigned a consensus recommendation of “Buy” from the eleven ratings firms that are currently covering the company, MarketBeat Ratings reports. Eleven equities research analysts have rated the stock with a buy rating. The average 12 month target price among analysts that have covered the stock in the last year is $86.09.

A number of equities research analysts have commented on the company. Evercore ISI assumed coverage on Astera Labs in a research report on Tuesday, April 16th. They issued an “outperform” rating and a $100.00 price target on the stock. Barclays started coverage on Astera Labs in a research report on Monday, April 15th. They issued an “overweight” rating and a $85.00 price target on the stock. Craig Hallum started coverage on Astera Labs in a research note on Monday, April 15th. They issued a “buy” rating and a $90.00 price objective on the stock. Jefferies Financial Group began coverage on Astera Labs in a research note on Monday, April 15th. They set a “buy” rating and a $85.00 price target on the stock. Finally, Needham & Company LLC began coverage on Astera Labs in a research note on Monday, April 15th. They issued a “buy” rating and a $85.00 price objective for the company.

Check Out Our Latest Analysis on ALAB

Insider Transactions at Astera Labs

In other Astera Labs news, Director Jack R. Lazar acquired 10,000 shares of the stock in a transaction that occurred on Friday, March 22nd. The shares were bought at an average price of $36.00 per share, for a total transaction of $360,000.00. Following the completion of the transaction, the director now owns 165,000 shares of the company’s stock, valued at approximately $5,940,000. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Institutional Investors Weigh In On Astera Labs

An institutional investor recently bought a new position in Astera Labs stock. Allspring Global Investments Holdings LLC acquired a new position in Astera Labs, Inc. (NASDAQ:ALABFree Report) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 251,596 shares of the company’s stock, valued at approximately $18,666,000. Allspring Global Investments Holdings LLC owned approximately 0.16% of Astera Labs as of its most recent filing with the Securities & Exchange Commission.

Astera Labs Price Performance

Shares of ALAB stock opened at $64.49 on Monday. Astera Labs has a twelve month low of $50.61 and a twelve month high of $95.21.

Astera Labs Company Profile

(Get Free Report

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Further Reading

Analyst Recommendations for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.